Question 1

What is Capricor Therapeutics, Inc.?

Accepted Answer

Capricor Therapeutics, Inc. is a biotechnology company that is developing transformative cell and exosome-based therapeutics, with a focus on Duchenne muscular dystrophy and other serious diseases.

Question 2

What is the company's approach to drug development?

Accepted Answer

Capricor Therapeutics is patient-focused and is advancing precision medicine through its multi-stage pipeline, which explores the use of allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches.

Question 3

What is Deramiocel?

Accepted Answer

Deramiocel is a biologic medicine being developed by Capricor Therapeutics for the treatment of Duchenne muscular dystrophy cardiomyopathy. The company has announced its intent to file a Biologics License Application (BLA) with the U.S. FDA for the full approval of Deramiocel.

Question 4

What is Capricor Therapeutics' scientific focus?

Accepted Answer

Capricor Therapeutics' science is focused on cell and exosome-based biology, offering multiple modalities that allow the company to create a new class of therapeutic medicines for patients.

Question 5

What is the company's pipeline?

Accepted Answer

Capricor Therapeutics has an optimized patient-focused pipeline that explores the use of allogeneic cardiosphere-derived cells (CDCs) and exosome science for the treatment of a broad range of serious diseases, including Duchenne muscular dystrophy.

Capricor Therapeutics

Company Overview

Company Name

Address

Website

Employees

About Capricor Therapeutics

Frequently Asked Questions about Capricor Therapeutics

What is Capricor Therapeutics, Inc.?

What is the company's approach to drug development?

What is Deramiocel?

What is Capricor Therapeutics' scientific focus?

What is the company's pipeline?

Social Profiles

Key Decision Makers